Richter BioLogics GmbH & Co. KG

Richter BioLogics is a leading Germany-based contract development and manufacturing company (CDMO) specialized in products derived from bacteria and yeasts. With capacities of currently 2 x 1,500L and 2 x 300L, our focus is on the production of plasmid DNA, antibodies (e.g. VHH/nanobodies), proteins, and vaccines. With a proven 35+ year track record our experienced and highly skilled teams support clients with process development, supply of products for clinical trials, commercial production, in-house QC testing, and QP release. Richter BioLogics consistently works to the highest standards of pharmaceutical quality. This has been verified by major regulatory bodies including EMA, FDA, ANVISA, PMDA and MFDS as well as by numerous customer audits.